These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 397800
1. Erythromycin levels in serum during treatment with erythromycin stearate and base. Saarni H, Kanto J, Allonen H. Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800 [Abstract] [Full Text] [Related]
2. Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives. Mäntylä R, Ailio A, Allonen H, Kanto J. Ann Clin Res; 1978 Oct; 10(5):258-62. PubMed ID: 367255 [Abstract] [Full Text] [Related]
3. Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally. McGimpsey JG, Webb CH, McCrea PH. Int J Oral Surg; 1981 Oct; 10(Suppl 1):198-202. PubMed ID: 6807878 [Abstract] [Full Text] [Related]
4. Absorption of erythromycin. A cross-over study in healthy volunteers. Männistö P, Tuomisto J, Räsänen R. Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445 [Abstract] [Full Text] [Related]
5. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections]. Bertrand A, Jonquet O, Sauvaget J. Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354 [Abstract] [Full Text] [Related]
6. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans. Ducci M, Scalori V, del Tacca M, Soldani G, Bernardini C, Grothe E, Bertelli A. Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242 [Abstract] [Full Text] [Related]
7. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine. De Bernardi M, Feletti F, Gazzani G, Fregnan GB. Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299 [Abstract] [Full Text] [Related]
8. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. Ginsburg CM, McCracken GH, Steinberg JB, Crow SD, Dildy BF, Lancaster K, Olsen K. Pediatr Infect Dis; 1982 Sep; 1(6):384-7. PubMed ID: 6761656 [No Abstract] [Full Text] [Related]
9. Erythromycin stearate, 1.5 g, for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and tolerance. Shanson DC, Akash S, Harris M, Tadayon M. J Antimicrob Chemother; 1985 Jan; 15(1):83-90. PubMed ID: 3882657 [Abstract] [Full Text] [Related]
10. Plasma and saliva concentrations for a new formulation of erythromycin stearate. Berend N, Rutland J, Marlin GE. Curr Med Res Opin; 1979 Jan; 6(2):118-23. PubMed ID: 467089 [Abstract] [Full Text] [Related]
11. Clinical and pharmacological evaluation of different preparations of oral erythromycin. Butzler JP, Vanhoof R, Clumeck N, de Mol P, Vanderlinden MP, Yourassowsky E. Chemotherapy; 1979 Jan; 25(6):367-72. PubMed ID: 316377 [Abstract] [Full Text] [Related]
12. [Pharmacodynamics of erythromycin lactobionate during tonsillectomy in children]. Leuthardt R, Trümpi B, Morger R. Schweiz Med Wochenschr; 1989 Oct 07; 119(40):1372-4. PubMed ID: 2799345 [Abstract] [Full Text] [Related]
16. Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in man. Parsons RL, David J, Paddock GM, Stamp ST. Postgrad Med J; 1978 Feb 07; 54(628):68-71. PubMed ID: 345253 [Abstract] [Full Text] [Related]
18. The efficacy of azithromycin in the treatment of acute infraorbital space infection. Al-Belasy FA, Hairam AR. J Oral Maxillofac Surg; 2003 Mar 07; 61(3):310-6. PubMed ID: 12618970 [Abstract] [Full Text] [Related]